RxDoctor Payments DataLook up a doctor →

FLUMIST QUADRIVALENT: payments to doctors

Payments that named FLUMIST QUADRIVALENT as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$6.1M
Providers
5,560
Transactions
7,307
Average per transaction
$840

The per-transaction average — $840 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 5,560 providers the average total is $1,104, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
AstraZeneca$6,106,98199.5%
Astrazeneca UK Limited$30,7300.5%
Acerta Pharma LLC$2270.0%
← All drugs & devices